Myalept
Generic name: Metreleptin
Drug class:
Miscellaneous metabolic agents
Usage of Myalept
Myalept is used together with diet to treat complications caused by leptin deficiency in people who have lipodystrophy (also called fat redistribution). Lipodystrophy (LIP-oh-DIS-tro-fee) is a problem with the way the body stores fat.
Myalept is not for use in people who have lipodystrophy caused by taking medicine to treat HIV or AIDS.
Myalept may also be used for purposes not listed in this medication guide.
Myalept side effects
Get emergency medical help if you have any signs of an allergic reaction to Myalept: hives; difficult breathing; rapid heart rate, feeling like you might pass out; swelling of your face, lips, tongue, or throat.
In some people, metreleptin can trigger an immune response to the medicine, making it less effective or causing certain side effects. Call your doctor if you develop:
Also call your doctor at once if you have:
Common Myalept side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Myalept
You should not use Myalept if you are allergic to metreleptin.
This medicine is not for use in treating obesity that is unrelated to leptin deficiency.
Myalept is available only from a certified pharmacy under a special program. You must be registered in the program and understand the risks of taking this medication.
To make sure Myalept is safe for you, tell your doctor if you have:
It is not known whether Myalept will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.
It is not known whether metreleptin passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.
Relate drugs
- Amvuttra
- Asfotase alfa
- Crysvita
- Myalept
- Burosumab
- Burosumab-twza
- Cerdelga
- Eliglustat
- Fosdenopterin
- Galafold
- Givlaari
- Givosiran
- Inotersen
- Kuvan
- Lonafarnib
- Lumasiran
- Metreleptin
- Migalastat
- Miglustat
- Mitapivat
- Nitisinone
- Nityr
- Nulibry
- Onpattro
- Opfolda
- Orfadin
- Oxlumo
- Palynziq
- Patisiran
- Pegvaliase
- Pegvaliase-pqpz
- Pyrukynd
- Pyrukynd Taper Pack
- Rivfloza
- Sapropterin
- Strensiq
- Tegsedi
- Vutrisiran
- Zavesca
- Zokinvy
How to use Myalept
Usual Adult Dose for Lipodystrophy:
40 Kg or less: -Initial dose: 0.06 mg/kg/day subcutaneously. Increase or decrease by 0.02 mg/kg -Maximum dose: 0.13 mg/kg/day Greater than 40 Kg: Males: -Initial dose: 2.5 mg/day subcutaneously. Increase or decrease by 1.25 to 2.5 mg/day -Maximum dose: 10 mg/day Female: -Initial dose: 5 mg/day subcutaneously. Increase or decrease by 1.25 to 2.5 mg/day -Maximum dose: 10 mg/day Uses: Replacement therapy for leptin deficiency in patients with congenital or acquired generalized lipodystrophy, as adjunct to diet.
Usual Pediatric Dose for Lipodystrophy:
40 Kg or less: -Initial dose: 0.06 mg/kg/day subcutaneously. Increase or decrease by 0.02 mg/kg -Maximum dose: 0.13 mg/kg/day Greater than 40 Kg: Males: -Initial dose: 2.5 mg/day subcutaneously. Increase or decrease by 1.25 to 2.5 mg/day -Maximum dose: 10 mg/day Female: -Initial dose: 5 mg/day subcutaneously. Increase or decrease by 1.25 to 2.5 mg/day -Maximum dose: 10 mg/day Comments: Use preservative-free sterile water for injection (WFI) to reconstitute metreleptin for pediatric injection. Uses: Replacement therapy for leptin deficiency in patients with congenital or acquired generalized lipodystrophy, as adjunct to diet.
Warnings
In some people, Myalept can trigger an immune response to the medicine, making it less effective or causing certain side effects. Call your doctor if you develop any signs of a new infection (fever, chills, night sweats, weight loss, swollen glands, flu symptoms), or worsening of your lipodystrophy symptoms. If you are diabetic, tell your doctor if you have any changes in your blood sugar levels.
What other drugs will affect Myalept
Other drugs may interact with metreleptin, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions